Cellectis (CLLS) Total Debt Growth (3y) (2017 - 2026)
Cellectis (CLLS) Total Debt Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 50.25% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 25.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 45.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.48% |
| Dec 31, 2025 | 48.84% |
| Sep 30, 2025 | 48.21% |
| Jun 30, 2025 | 40.09% |
| Mar 31, 2025 | 29.89% |
| Dec 31, 2024 | 44.13% |
| Sep 30, 2024 | 43.25% |
| Jun 30, 2024 | 39.31% |
| Mar 31, 2024 | 34.29% |
| Dec 31, 2023 | 23.57% |
| Sep 30, 2023 | 15.35% |
| Jun 30, 2023 | 63.41% |
| Dec 31, 2022 | 188.49% |
| Dec 31, 2021 | 154.93% |
| Sep 30, 2021 | 260.49% |
| Jun 30, 2021 | 186.05% |
| Mar 31, 2021 | 332.07% |
| Dec 31, 2020 | 846.57% |
| Sep 30, 2020 | 781.17% |
| Jun 30, 2020 | 393.14% |